Dr. Eagleton is investigating the processes leading to the development of an abdominal aortic aneurysm, a potentially fatal bulge or ballooning of the main artery leading from the heart to lower portions of the body. Currently, the only available treatment for aortic aneurysm disease is surgical repair. Dr. Eagleton’s goal is to develop a drug therapy that will limit the growth of an aneurysm or prevent it from forming.
Dr. Eagleton’s specialty interests include endovascular and open surgery for complex aortic disease, aneurysm pathogenesis, pediatric and congenital vascular disease, and vessel wall matrix remodeling.
Currently Dr. Eagleton is the sponsor and principal investigator on several Investigation Device Exemption studies evaluating the use of branched and fenestrated aortic endografts to treat complex aortic pathology. In addition to the above research, Dr. Eagleton is involved in research related to engineering stent graft design and investigating alternate methods of intraoperative imaging.